An international team of scientists, led by researchers from Temple University School of Medicine, has found that a source of mounting genomic chaos, or instability, common to chronic myeloid leukemia may lie in a pool of leukemia stem cells that are immune to treatment with potent targeted anticancer drugs.
http://www.medilexicon.com/medicalnews.php?newsid=253944
http://www.medilexicon.com/medicalnews.php?newsid=253944
No comments:
Post a Comment